Theriva Biologics, Inc. - 10-Q Filing

Theriva Biologics reports financial results for the quarterly period ended September 30, 2026.

SEC EDGAR · November 12, 2026, 13:15 UTC

Tickers: $TOVX

More Regulatory news

Yesway, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 13:31 UTC
RUM Group Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 13:31 UTC
ALLIANCE ENTERTAINMENT HOLDING CORP - 10-Q Filing SEC EDGAR · November 12, 2026, 13:31 UTC
GT Biopharma, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:30 UTC
HeartCore Enterprises, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:30 UTC
Agassi Sports Entertainment Corp. - 8-K Filing SEC EDGAR · November 12, 2026, 13:30 UTC
M2i Global, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:30 UTC
Talen Energy Corp - 8-K Filing SEC EDGAR · November 12, 2026, 13:30 UTC
VisionWave Holdings, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:30 UTC
Incannex Healthcare Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 13:29 UTC